Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Elite Auctions Presents Rare 8,250-SF Luxury Turnkey Residence in Aspen, CO at Auction to the Highest Bidder on July 15
-
American Rebel Signs Distribution Agreement with Dichello Distributors for the state of Connecticut
-
TEN, Ltd. Holds its Thirty First Annual General Meeting
-
YY Group to Ring the Nasdaq Stock Market Opening Bell
-
Coca-Cola Consolidated Announces Final Results of Tender Offer
-
Vivoryon Therapeutics N.V. Reports Outcome of 2024 Annual General Meeting
-
Extension of the powers of a member of the Management Board of OÜ TS Laevad – a subsidiary of AS Tallinna Sadam
-
Invesco Ltd: Form 8.3 - DS Smith PLC
-
Invesco Ltd: Form 8.3 - Bellway PLC
-
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
-
Invesco Ltd: Form 8.3 - Alpha Financial Markets Consulting PLC
-
Great Pacific Gold Announces New High-Grade Assays at Comet Discovery Including 4m at 22.3 g/t Gold
-
Governor General of Canada Extends Viceregal Patronage to United for Literacy
-
Tenneco's Monroe Intelligent Suspension-Equipped Rivian R1T Targeting New Heights in Saturday’s Pikes Peak Hill Climb
-
West Bancorporation, Inc. to Announce Quarterly Results, Hold Conference Call
-
Lead Real Estate Co., Ltd Announces Voluntary Lock-up Restrictions for Management and Senior Officers
-
Tenneco's Monroe Intelligent Suspension-Equipped Rivian R1T Targeting New Heights in Saturday’s Pikes Peak Hill Climb
-
DigiAsia Corp. Announces Execution of Definitive Agreements for a Convertible Note Financing with Helena Partners
-
Selectis Health Completes Sale of Archway Transitional Care Center in Georgia
-
SEALSQ to Participate in Northland Growth Conference
-
Invesco Ltd: Form 8.3 - Virgin Money UK PLC
-
Form 8.3 - AXA INVESTMENT MANAGERS: Darktrace plc
-
Alliance Trust PLC - Net Asset Value
-
Form 8.3 - Irish Residential Properties REIT plc
-
Palisade Bio Provides Update on Advancement of its Strategic Collaboration with Strand Life Sciences
-
Form 8.3 - Keywords Studios Plc
-
Form 8.3 - Balanced Commercial Property Trust Limited
-
Invesco Ltd: Form 8.3 - Quanex Building Products Corp Public dealing disclosure
-
Form 8.3 - Alpha Financial Markets Consulting Plc
-
Starton Therapeutics Announces 100% Partial Response or Better in Multiple Myeloma Patients in Interim, Top-line Data from STAR-LLD Phase 1b Clinical Trial
-
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
-
Acasti Announces Year-End 2024 Financial Results, Provides Business Update
-
The Washington Post Recognizes HRCI as a 2024 Top Workplace
-
TESSAN Announces Collaboration with NatGeo Explorer and Photographer Mattias Klum
-
Pan American Energy Announces Completion of the Spring 2024 Field Prospecting and Sampling Program at the Big Mack Lithium Project
-
2024-25 Minister’s Special Licence Auction (MSLA) Funding Recipients
-
Lexicon Pharmaceuticals Resubmits Sotagliflozin NDA for Type 1 Diabetes
-
LGI Homes Opens New Community in the Atlanta Area
-
Lifetime Brands, Inc. Announces Results of 2024 Annual Meeting
-
Super Hi Announces Changes to Executive Leadership and Board Composition
-
TESSAN Announces Collaboration with NatGeo Explorer and Photographer Mattias Klum
-
Bukit Jalil Global Acquisition 1 Ltd. Postponed the Extraordinary General Meeting to June 28, 2024 and Extended the Redemption Request Deadline
-
Landmark Nature Medicine Study Reports Promising New Treatment Reduces Suffering in Sanfilippo syndrome
-
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
-
Aprea Therapeutics to Host Virtual KOL Event on APR-1051, a Highly Selective and Potentially Best-in-Class Oral WEE1 Inhibitor, on Monday, June 24, 2024
-
Rectitude Holdings Ltd Announces Pricing of Initial Public Offering
-
Ascent Solar Technologies Announces Debt Pay Off for Outstanding Balances
-
Super League Issues Mid-Year Update, Expects Record 2024 Revenues
-
Monarch Private Capital Releases 2023 Impact Report: “Touchpoints”
-
Iterum Therapeutics Announces FDA Advisory Committee Meeting to discuss NDA for Oral Sulopenem for the treatment of Uncomplicated Urinary Tract Infections
